Strategic Entrance
Growth Stages

Operating priorities change as the company advances.

The right operating model depends on more than headcount. It reflects scientific maturity, organizational complexity, ownership, regulatory exposure and the path toward commercialization.

Early-stage life-science leaders planning laboratory capacity and organizational growth
What changes with growth

Each stage shifts the operating focus.

As the organization grows, informal coordination gives way to repeatable systems, broader accountability and increasingly regulated ways of working.

01

People

Specialists, managers and cross-functional ownership emerge as employee count and coordination needs increase.

02

Operating footprint

Vendors, systems, laboratories, sites and infrastructure become more interconnected and harder to manage informally.

03

Company context

Private-company flexibility evolves toward public-company controls, disclosure discipline and predictable execution.

04

Science & quality

Research practices progress from fit-for-purpose foundations to GxP controls embedded wherever regulated work requires them.

The operating journey

Build for the stage you are entering.

Employee ranges are directional. Program complexity, regulatory commitments, facilities and business strategy often matter more than the number itself.

01
Early research

Discover

Typical scale1–25 employees
Company contextPrivate; founder-led
DevelopmentDiscovery and R&D
Quality postureFoundational; non-GxP

Keep the operating footprint light while protecting people, science, data and intellectual property.

  • Choose flexible vendors and core systems
  • Establish security, safety and data basics
  • Clarify ownership without adding hierarchy
  • Preserve options for the next financing and program stage
02
Preclinical growth

Build

Typical scale25–75 employees
Company contextPrivate; venture-backed
DevelopmentPreclinical and IND-enabling
Quality postureGxP roadmap begins

Turn a research team into a company while keeping structure proportionate to near-term scientific and financing milestones.

  • Formalize operating rhythms and decision rights
  • Plan laboratory capacity and critical infrastructure
  • Strengthen vendor governance and business continuity
  • Identify where regulated processes will first appear
03
Early clinical

Scale

Typical scale75–150 employees
Company contextPrivate or preparing to go public
DevelopmentPhase 1 and early clinical
Quality postureTargeted GxP implementation

Expand people, systems and facilities together as clinical work introduces new dependencies, evidence requirements and operating risk.

  • Implement GxP controls in regulated workflows
  • Improve identity, access, data and system governance
  • Build capacity models across people, space and equipment
  • Prepare SOX controls, supporting systems and reporting for public-company readiness
04
Clinical expansion

Mature

Typical scale150–300+ employees
Company contextPublic or late-stage private
DevelopmentMulti-program clinical portfolio
Quality postureGxP embedded across functions

Increase predictability and resilience while supporting more programs, partners, systems and sites.

  • Standardize cross-functional processes, SOX controls and supporting systems
  • Validate systems and strengthen inspection readiness
  • Expand continuity, cybersecurity and risk programs
  • Balance enterprise controls with scientific speed
05
Late clinical to commercial

Expand

Typical scale300+ or distributed enterprise
Company contextPublic; partnered or global
DevelopmentLate clinical, launch and commercial
Quality postureEnd-to-end GxP operating model

Connect development, supply, quality and commercial operations without losing clarity or accountability.

  • Prepare launch, supply and commercial capabilities
  • Scale validated platforms and enterprise data
  • Coordinate multi-site and partner operations
  • Build resilience for sustained regulated performance
A practical principle

Complexity—not headcount alone—determines what
comes next.

A 40-person company operating laboratories and clinical programs may need more structure than a 100-person virtual organization.

The objective is not to imitate a larger enterprise. It is to mature the few capabilities required for the next stage while preserving speed, capital and strategic flexibility.

Ready to build what’s next?

Let’s discuss your priorities, timing, and the support you need. Before work begins, we agree on deliverables, responsibilities, timing, and fees in a written scope.

Start a Conversation